318 related articles for article (PubMed ID: 16243196)
1. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
[TBL] [Abstract][Full Text] [Related]
2. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
Walsh M; Fromm G
Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
[No Abstract] [Full Text] [Related]
3. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department.
Johnson M; Bakas T
J Neurosci Nurs; 2010 Apr; 42(2):88-94. PubMed ID: 20422794
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis in stroke: still not ready for community hospital use by emergency physicians.
McNamara RM
Ann Emerg Med; 2009 Sep; 54(3):339-41. PubMed ID: 19695417
[No Abstract] [Full Text] [Related]
5. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
Charipar R; Charipar E
WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
[TBL] [Abstract][Full Text] [Related]
6. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
[TBL] [Abstract][Full Text] [Related]
7. Why are eligible thrombolysis candidates left untreated?
Hills NK; Johnston SC
Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
[TBL] [Abstract][Full Text] [Related]
8. Medicine. Stroke--tPA and the clinic.
Marler JR; Goldstein LB
Science; 2003 Sep; 301(5640):1677. PubMed ID: 14500967
[TBL] [Abstract][Full Text] [Related]
9. Agreement with evidence for tissue Plasminogen Activator use among emergency physicians: a cross-sectional survey.
Grady AM; Bryant J; Carey ML; Paul CL; Sanson-Fisher RW; Levi CR
BMC Res Notes; 2015 Jun; 8():267. PubMed ID: 26111807
[TBL] [Abstract][Full Text] [Related]
10. Attitudes and approaches to acute ischemic stroke in Wisconsin hospitals.
Dulli DA; Dempsey RJ; Levine RL
WMJ; 2001; 100(5):44-9. PubMed ID: 11579800
[TBL] [Abstract][Full Text] [Related]
11. Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians.
Leira EC; Pary JK; Davis PH; Grimsman KJ; Adams HP
Arch Neurol; 2007 Apr; 64(4):518-21. PubMed ID: 17420312
[TBL] [Abstract][Full Text] [Related]
12. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
Bledsoe BE
Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
[No Abstract] [Full Text] [Related]
13. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
[TBL] [Abstract][Full Text] [Related]
14. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
Whitcomb DS
Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
[No Abstract] [Full Text] [Related]
15. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial.
LaMonte MP; Bahouth MN; Magder LS; Alcorta RL; Bass RR; Browne BJ; Floccare DJ; Gaasch WR;
Ann Emerg Med; 2009 Sep; 54(3):319-27. PubMed ID: 19101059
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus.
Levi CR; ; ;
Med J Aust; 2004 Jun; 180(12):634-6. PubMed ID: 15200362
[TBL] [Abstract][Full Text] [Related]
17. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.
Silverman IE; Beland DK; Chhabra J; McCullough LD
Conn Med; 2005; 69(10):613-20. PubMed ID: 16381108
[TBL] [Abstract][Full Text] [Related]
18. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
19. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments.
Switzer JA; Hall C; Gross H; Waller J; Nichols FT; Wang S; Adams RJ; Hess DC
J Emerg Med; 2009 Jan; 36(1):12-8. PubMed ID: 18242925
[TBL] [Abstract][Full Text] [Related]
20. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
